TBPH Insider Trading Activity and SEC Form 4 Filings
TBPH insider trading summary
Over the past 12 months, insiders at Theravance Biopharma, Inc. (TBPH) reported 17 sales worth $3.1M by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $3.1M.
Latest TBPH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Rhonda Farnum | SVP, Comm & Medical Affairs | Sell | $57K (3,328 @ $17.03) |
| Sep 15, 2026 | Rhonda Farnum | SVP, Comm & Medical Affairs | Sell | $57K (3,329 @ $17.03) |
| Sep 15, 2026 | Rhonda Farnum | SVP, Comm & Medical Affairs | Sell | $113K (6,657 @ $17.03) |
| Jun 15, 2026 | Rhonda Farnum | SVP, Comm & Medical Affairs | Sell | $55K (3,329 @ $16.39) |
| Jun 15, 2026 | Rhonda Farnum | SVP, Comm & Medical Affairs | Sell | $55K (3,328 @ $16.38) |
| Jun 15, 2026 | Rhonda Farnum | SVP, Comm & Medical Affairs | Sell | $109K (6,657 @ $16.39) |
| Mar 16, 2026 | Rhonda Farnum | SVP, Comm & Medical Affairs | Sell | $108K (7,767 @ $13.92) |
| Mar 16, 2026 | Rhonda Farnum | SVP, Comm & Medical Affairs | Sell | $217K (15,534 @ $14.00) |
| Mar 16, 2026 | Rhonda Farnum | SVP, Comm & Medical Affairs | Sell | $108K (7,766 @ $13.92) |
| Dec 3, 2025 | Rhonda Farnum | SVP, Comm & Medical Affairs | Sell | $146K (7,767 @ $18.75) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.